{"id":32379,"date":"2018-05-20T12:00:00","date_gmt":"2018-05-20T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/"},"modified":"2018-05-20T12:00:00","modified_gmt":"2018-05-20T12:00:00","slug":"lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/","title":{"rendered":"Lessen uit biologicals bij astma voor de KNO-heelkunde"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1384 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Brussel 2017<\/h2>\n<p>Verschillende biologische therapie\u00ebn, die zich voornamelijk richten op type 2-inflammatie, zijn effectief gebleken in het verminderen van astma-exacerbaties, werken corticostero\u00efdbesparend, verbeteren de longfunctie en\/of verhogen de kwaliteit van leven bij pati\u00ebnten met ernstig astma. Er is steeds meer bewijs dat deze therapie\u00ebn ook effectief zijn bij aandoeningen van de bovenste luchtwegen, zoals chronische rhinosinusitis met neuspoliepen (CRSwNP), en dat zij de omvang van neuspoliepen kunnen verminderen, de kwaliteit van leven van pati\u00ebnten kunnen verbeteren en een positieve invloed kunnen hebben op de uitkomstparameters van de lagere luchtwegen. <\/p>\n<h3>Panelleden<\/h3>\n<p>Prof. Peter Hellings, Prof. Claus Bachert, Prof. Wytske Fokkens, Prof. Guy Joos, Prof. Renaud Louis, Prof. Charles Pilette, Prof. Glenis Scadding, Dr. David Price en pati\u00ebntenvertegenwoordigers.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1385 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-videospeler\" src=\"https:\/\/www.youtube.com\/embed\/QzM18SRCaDw?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Brussel 2017 Verschillende biologische therapie\u00ebn, die zich voornamelijk richten op type 2-inflammatie, zijn effectief gebleken in het verminderen van astma-exacerbaties, werken corticostero\u00efdbesparend, verbeteren de longfunctie en\/of verhogen de kwaliteit van leven bij pati\u00ebnten met ernstig astma. Er is steeds meer bewijs dat deze therapie\u00ebn ook effectief zijn bij aandoeningen van de bovenste luchtwegen, zoals chronische rhinosinusitis met neuspoliepen (CRSwNP), en dat zij de omvang van neuspoliepen kunnen verminderen, de kwaliteit van leven van pati\u00ebnten kunnen verbeteren en een positieve invloed kunnen hebben op de uitkomstparameters van de lagere luchtwegen. Panelleden Prof. Peter Hellings, Prof. Claus Bachert, Prof. Wytske Fokkens, Prof. Guy Joos, Prof. Renaud Louis, Prof. Charles Pilette, Prof. Glenis Scadding, Dr. David Price en pati\u00ebntenvertegenwoordigers.<\/p>\n","protected":false},"author":1,"featured_media":32399,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[233],"tags":[223,234,235,236,150,152],"class_list":["post-32379","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-astma","tag-rhinologie","tag-debatten","tag-rhinology-future-debates","tag-chronische-rhinosinusitis-crs","tag-crswnp"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Lessen uit biologicals bij astma voor de KNO-heelkunde - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lessen uit biologicals bij astma voor de KNO-heelkunde\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Brussel 2017 Verschillende biologische therapie\u00ebn, die zich voornamelijk richten op type 2-inflammatie, zijn effectief gebleken in het verminderen van astma-exacerbaties, werken corticostero\u00efdbesparend, verbeteren de longfunctie en\/of verhogen de kwaliteit van leven bij pati\u00ebnten met ernstig astma. Er is steeds meer bewijs dat deze therapie\u00ebn ook effectief zijn bij aandoeningen van de bovenste luchtwegen, zoals chronische rhinosinusitis met neuspoliepen (CRSwNP), en dat zij de omvang van neuspoliepen kunnen verminderen, de kwaliteit van leven van pati\u00ebnten kunnen verbeteren en een positieve invloed kunnen hebben op de uitkomstparameters van de lagere luchtwegen. Panelleden Prof. Peter Hellings, Prof. Claus Bachert, Prof. Wytske Fokkens, Prof. Guy Joos, Prof. Renaud Louis, Prof. Charles Pilette, Prof. Glenis Scadding, Dr. David Price en pati\u00ebntenvertegenwoordigers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/\",\"name\":\"Lessen uit biologicals bij astma voor de KNO-heelkunde - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017_3.png\",\"datePublished\":\"2018-05-20T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017_3.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017_3.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Lessen uit biologicals bij astma voor de KNO-heelkunde\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Lessen uit biologicals bij astma voor de KNO-heelkunde - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/","og_locale":"nl_NL","og_type":"article","og_title":"Lessen uit biologicals bij astma voor de KNO-heelkunde","og_description":"Rhinology Future Debates Brussel 2017 Verschillende biologische therapie\u00ebn, die zich voornamelijk richten op type 2-inflammatie, zijn effectief gebleken in het verminderen van astma-exacerbaties, werken corticostero\u00efdbesparend, verbeteren de longfunctie en\/of verhogen de kwaliteit van leven bij pati\u00ebnten met ernstig astma. Er is steeds meer bewijs dat deze therapie\u00ebn ook effectief zijn bij aandoeningen van de bovenste luchtwegen, zoals chronische rhinosinusitis met neuspoliepen (CRSwNP), en dat zij de omvang van neuspoliepen kunnen verminderen, de kwaliteit van leven van pati\u00ebnten kunnen verbeteren en een positieve invloed kunnen hebben op de uitkomstparameters van de lagere luchtwegen. Panelleden Prof. Peter Hellings, Prof. Claus Bachert, Prof. Wytske Fokkens, Prof. Guy Joos, Prof. Renaud Louis, Prof. Charles Pilette, Prof. Glenis Scadding, Dr. David Price en pati\u00ebntenvertegenwoordigers.","og_url":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/","url":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/","name":"Lessen uit biologicals bij astma voor de KNO-heelkunde - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017_3.png","datePublished":"2018-05-20T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017_3.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017_3.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/nl\/news\/lessen-uit-biologicals-bij-astma-voor-de-kno-heelkunde\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/nl\/news\/"},{"@type":"ListItem","position":3,"name":"Lessen uit biologicals bij astma voor de KNO-heelkunde"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/nl\/#website","url":"https:\/\/www.euforea.org\/nl\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/nl\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/32379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=32379"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/32379\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/32399"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=32379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=32379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=32379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}